Mounjaro is a new injectable medication approved for both type 2 diabetes and weight management. It works by mimicking gut hormones that regulate appetite and blood sugar.
Mounjaro can be a long-term medication for adults with type 2 diabetes or obesity, but it is not suitable for everyone, especially pregnant women or people with a history of pancreatitis. The medication can cause side effects like nausea and vomiting, but there are ways to manage them. Mounjaro seems effective in reducing weight and blood sugar, but more research is needed to confirm its long-term safety and benefits.
Original article posted here: https://www.thelondonobesityclinic.com/is-mounjaro-tirzepatide-a-long-term-medication/